| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.09 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.27 | 0.09 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |